Market Overview The global antibody-drug conjugates (ADCs) market was valued at approximately USD 14.3 billion in 2025 and is projected to reach USD 51.6 billion by 2035, registering a compound annual growth rate (CAGR) of 13.7% from 2025 to 2035. The market is experiencing significant growth as pharmaceutical and biotechnology companies increasingly invest in targeted cancer therapies that...